Apollo Hospitals Enterprise Ltd

The transcript from the Q1 FY25 earnings call of Apollo Hospitals Limited (Page 16 and other pages) does not mention any current or future plans for fundraising through debt or equity. Key points related to financial strategies include: - Focus on profitability enhancement and operational excellence. - Maintaining guidance on growth and EBITDA margins without revision. - Investment in new initiatives and expansions primarily funded through existing operations. - No explicit mention of raising funds via debt or equity in the near term. Thus, based on the call transcript, there is no disclosed plan for new fundraising through debt or equity at this time.

- Apollo Hospitals plans to operationalize 4 new hospitals adding 1,500 beds in key markets: Gurgaon, Kolkata, Hyderabad, and Pune within the next 5 quarters. - There is a brownfield expansion in Mysore with 140 beds. - Investments are being made in expanding specialty manpower and diagnostic capacity. - Apollo HealthCo is investing in omni-channel customer acquisition, digital therapeutics, insurance, and app monetization, aiming for breakeven in 6-7 quarters. - The company is experimenting with faster medicine delivery models for acute/emergency customers. - Cost optimization and calibrated growth investments are ongoing to support expansion while managing operational expenses.

- Healthcare Services revenue grew 15% YoY; expected continued double-digit volume growth driven by quality and insurance coverage expansion. - Anticipated ARPOB growth improvement over next quarters due to better case mix and increased surgical volume. - Hospitals to operationalize 4 new facilities (Gurgaon, Kolkata, Hyderabad, Pune) adding 1,500 beds over next 5 quarters, aiding volume growth. - Pharmacy business expects 50% growth over last year, with recovery in Q2 and Q3 post-operating model changes. - Apollo 24/7 platform GMV growing at 9%; growth expected to accelerate in next two quarters, targeting break-even in 6-7 quarters. - Offline pharmacy store additions projected at 500–550 stores annually, boosting distribution revenue. - Digital and corporate channels, insurance, and digital therapeutics seen as key drivers for future growth and margin expansion. - Focus remains on volume-driven growth over ARPOB for sustainable profitability.

- Apollo Hospitals is optimistic about its growth trajectory across all business verticals for FY25 and beyond (page 16). - Healthcare Services revenue grew 15% YoY; occupancy increased by 600 bps, expected to sustain or improve (pages 2, 9). - EBITDA margins in Healthcare Services expected to expand by 100 bps over next 3-4 quarters due to volume growth, better case mix, and cost optimization (pages 2, 7). - Apollo 24/7 digital segment aims for breakeven within 6-7 quarters, with margin improvement expected as pharmacy mix improves and new verticals contribute (pages 13). - Pharmacy segment discounts reduced; growth expected to normalize with 50% annual GMV growth target maintained (pages 12, 6). - Hospital EBITDA margins are expected to be 100-150 bps lower in FY26 due to new units but overall improving profitability due to volume and operational efficiencies (page 10). - Consolidated PAT grew 83% YoY; management expects further steady improvements through strategic initiatives (page 3).

The transcript provided from the AHEL Q1 FY25 Earnings Call does not contain any specific information regarding the current or expected order book or pending orders for Apollo Hospitals or its subsidiaries. The discussion primarily revolves around business performance metrics like occupancy, revenue growth, pharmacy discounting, customer acquisition costs, and expansion plans, but it does not mention order book status or pending order details.